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1 Deceased.The goal of this pilot study was to assess the effects of acute hypoglycemia on retinal function and con-
trast sensitivity in individuals with and without diabetes. Hyperinsulinemic hypoglycemic and euglyce-
mic clamp procedures were performed in subjects without diabetes (n = 7) and with controlled type 1
diabetes (n = 5). Mean age was 28 years, and none had retinal disease. During euglycemia (glucose 95–
110 mg/dl) and acute hypoglycemia (glucose 50–55 mg/dl), contrast sensitivity was measured and spatial
retinal responses were recorded with multifocal electroretinograms (mfERG), a rapid technique for map-
ping sensitivity from the foveal, macular and peripheral areas of the retina. During hypoglycemia, retinal
responses (mfERG P1 wave) were decreased in both type 1 diabetes subjects and subjects without diabe-
tes. The dominant effect was in the amplitude of the responses in the central macular retina, not in their
temporal properties. Responses from the central region, central 100, were on average 1.8-fold lower than
those from the periphery for both groups. All diabetes subjects and 3/7 without diabetes reported central
scotoma. Decreases in mfERG amplitude were accompanied by decreases in contrast sensitivity. These
changes were immediately reversed with the restoration of euglycemia. Overall, this study demonstrates
that the acute effects of hypoglycemia in the human eye predominantly involve central vision, and these
visual effects originate, at least in part, in the retina. The association between low blood glucose levels
and impaired central vision underscores the importance of avoiding when possible and promptly treating
hypoglycemia, particularly in individuals with diabetes.
Published by Elsevier Ltd.1. Introduction
Visual disturbances occur in individuals with diabetes during
hypoglycemia (Goldgewicht, Slama, Papoz, & Tchobroutsky,
1983; Hepburn et al., 1991; McCrimmon, Deary, Huntly, MacLeod,
& Frier, 1996; Tabandeh, Ranganath, & Marks, 1996). Acute de-
creases in blood glucose levels have been associated with diplopia,
dimness of vision, blurred vision and loss of contrast sensitivity. In
the isolated cat eye, decreased glucose concentrations were associ-
ated with reductions in retinal sensitivity, with rods being more af-
fected than cones (Macaluso, Onoe, & Niemeyer, 1992). Mice with
chronic hypoglycemia have loss of vision, reduction of retinal re-
sponses and increased retinal cell death (Umino et al., 2006). The
direct effects of hypoglycemia on retinal function in humans are
unclear.
We report, for the ﬁrst time, the effects of acute hypoglycemia
on the human retina under photopic conditions in subjects with
and without diabetes. The effects of acute hypoglycemia on the
amplitude of retinal responses and their spatial distribution wereLtd.
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tock).examined using the multifocal electroretinogram (mfERG). Using
a complex, time-dependent visual stimulus in combination with
a standard ERG contact lens recording system, the mfERG provides
a rapid technique for mapping sensitivity from the foveal, macular
and peripheral areas of the retina (Bearse & Sutter, 1996; Curcio,
Sloan, Kalina, & Hendrickson, 1990; Hood, 2000; Marmor et al.,
2003; Sutter & Tran, 1992). We also assessed the effects of acute
hypoglycemia on visual contrast sensitivity.2. Materials and methods
2.1. Subjects
Participants with type 1 diabetes (mean hemoglobin A1c 7.2%)
were treated with multiple daily insulin injections or insulin pump
therapy. Exclusion criteria included a history of cardiovascular or
cerebrovascular disease, uncontrolled hypertension, seizures, head
trauma, eye disease, nephropathy, neuropathy, or hypoglycemia
unawareness, abnormal electrocardiogram, hemoglobin A1c >8%,
anemia, positive pregnancy test, renal or electrolyte abnormalities.
A dilated eye examination was performed by an ophthalmologist
prior to study to exclude retinal disease including retinopathy. This
study was approved by the Institutional Review Board for the Pro-
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subjects signed informed consent.
2.2. Hyperinsulinemic hypoglycemic and euglycemic clamp procedure
(Andres, Swerdloff, Pozefsky, & Coleman, 1966)
Participants arrived at the Clinical Research Unit after an over-
night fast. Vital signs were recorded and an intravenous catheter
inserted in the left hand dorsal vein in a retrograde fashion for
blood glucose sampling. The hand was placed in the hand warming
box maintained at 55 C to arterialize the venous blood (Liu et al.,
1992). Another intravenous catheter was inserted in the right ante-
cubital vein for insulin and 20% dextrose infusion. Glucose levels
were measured every 5 min at the bedside using the glucose oxi-
dase method (Beckman Instruments, Fullerton, CA). A primed con-
tinuous infusion of 80-mUm2 min1 of Regular human insulin
was used; 20% dextrose infusion was adjusted to achieve euglyce-
mia with a target blood glucose level of 90–110 mg/dl (5–
6.1 mmol/l). After an equilibration phase of 45 min, the 20% dex-
trose infusion rate was decreased slowly over a period of 45–
60 min to attain hypoglycemia with a target blood glucose level
of 50–55 mg/dl (2.7–3.1 mmol/l). The hypoglycemic phase was
maintained for 20 min. The rate of dextrose infusion was then in-
creased over 30–45 min to re-attain euglycemia. Subjects were of-
fered meals at the conclusion of the study. Subjects remained
rested and blinded to their blood glucose concentrations through-
out the study.
2.3. Multifocal electroretinogram (mfERG) recording
Local responses from multiple retinal areas were recorded by
using the mfERG technique (VERIS; Electro-Diagnostic Imaging,
San Mateo, CA, USA). A stimulus array of 103 or 241 hexagons cov-
ering 40 of retinal area was displayed at a frame rate of 75 Hz on a
Veris stimulator/camera. The hexagonal area was scaled with
eccentricity. A binary m-sequence was used. The mfERG stimulator
was presented in an otherwise dark-adapted room. Each subject’s
right pupil was dilated to a diameter of P7 mm with 1% tropica-
mide. After topical anesthesia with 0.5% tetracaine, a Burian Allen
bipolar contact lens electrode (Hansen Ophthalmic Laboratories,
Iowa City, IA) was placed on the test eye. A few drops of contact
lens rewetting solution were applied to the inner surface of contact
lens for better corneal contact. A ground electrode was placed on
the forehead. The left eye was covered with an eye patch. The focus
dial of the Veris refractor camera was adjusted so that the central
ﬁxation point marked by an ‘‘x’’ was in the best focus of the subject,
as depicted by a sharp image of subject’s eye on the examiner’s
monitor. The total duration of one recording (consistent of 16 seg-
ments and including breaks) was approximately 15 min, including
7 min and 17 s of recording usable data. Subjects were required to
maintain ﬁxation during the recording of a segment. However,
they could rest after a segment had been recorded. Subject ﬁxation
was monitored by real-time infrared viewing of the eye image dis-
played on the examiner’s monitoring screen. If loss of ﬁxation or an
artifact was observed, the affected segment was discarded and re-
recorded. Responses were ampliﬁed (Grass instruments), ﬁltered
(10–300 Hz), sampled and processed on a G4 PowerMac. The Buri-
an Allen contact lens electrode was removed from the eye after
obtaining the mfERG during hypoglycemia, and reinserted when
euglycemia was achieved.
2.4. Analysis of the mfERG
The typical waveform of the mfERG response is a biphasic wave
with an initial negative deﬂection (N1) followed by a positive peak
(P1) wave. The P1 wave corresponds to the b wave of the full ﬁeldelectroretinogram (Hood, Seiple, Holopigian, & Greenstein, 1997).
The corneal negative a-wave (corresponding to the N1 wave of
mfERG) provides information about phototransduction processes.
The corneal positive b-wave (corresponding to the P1 wave of
mfERG) represents the postphototransduction responses.
Peak-to-peak amplitude from trough of the ﬁrst negative wave
(N1) to the peak of the following positive wave (P1) was measured
during hypoglycemia and euglycemia. The P1 wave amplitude for
the rings 1–3 for 241 setting and rings 1 and 2 for 103 setting
was averaged to obtain mean P1 wave amplitude for central retinal
function. The P1 wave amplitude for rings 7–9 for 241 setting and
rings 5 and 6 for 103 setting was averaged to obtain mean P1wave
amplitude for the peripheral retinal response. The effect of hypo-
glycemia on P1 wave amplitude of central and peripheral retinal
response was determined. The 3-dimensional density response
was plotted during hypoglycemia and euglycemia.
Data are expressed as mean ± SEM. Data were analyzed by t-
tests for comparisons between percent changes in P1 wave ampli-
tudes in central and peripheral retina during hypoglycemia and
euglycemia.
2.5. Contrast sensitivity
Subjects read letters on a Pelli–Robson contrast sensitivity chart
(Haag-Streit, Essex, UK) from a distance of 1 m. The pupil of the eye
tested was not dilated and the other eye was occluded with an eye
patch. At least 20 s were allowed for subjects to identify the letters.3. Results
3.1. Glucose levels of participants
Seven subjects (5 females, 2 males) without diabetes (mean age
28 year; range 22–40 years) and ﬁve subjects (all males) with type
1 diabetes (mean age 28 years; range 23–35 years) participated.
For individuals with and without diabetes, the mean glucose levels
during euglycemia were 98 mg/dl and 99 mg/dl, and during hypo-
glycemia 53 mg/dl and 50 mg/dl respectively.
3.2. P1 wave amplitude
The P1 wave amplitude was higher during euglycemia than
hypoglycemia and decreased with reduction in blood glucose lev-
els in both the normal volunteers and subjects with diabetes. The
magnitude of amplitude changes was about equal for both groups,
but the effects of hypoglycemia were not uniformly distributed
across the retina. The reduction in P1 wave amplitude in the cen-
tral retina was signiﬁcantly greater than that observed in the
peripheral retina during acute hypoglycemia in both groups (Ta-
ble 1). Hypoglycemia modulated the amplitude of the mfERG but
not its temporal properties. No detectable changes were recorded
in the onset (or implicit times) of the mfERG components. The
changes in amplitude reversed immediately with restoration of
euglycemia. There were no timing differences between subjects
with and without diabetes.
3.3. 3-dimensional (3-D) response
The 3-D distribution reﬂects the electrical response density at
different retinal locations. These plots show the overall strength
per unit area of retina (combining N and P components) and were
obtained by dividing the response amplitude by the area of the
hexagon. In a normal subject the highest response densities are
achieved in the foveolar region, reﬂected by a peak in the central
area of this electrical map.
Table 1
Percent decrease in P1 wave amplitude in central and peripheral retina from euglycemia to hypoglycemia.
Subject Mean glucose during hypoglycemia (mg/dl) Central retina (% reduction) Peripheral retina (% reduction)
Normal volunteers
1 48 37 17
2 50 19 12
3 50 6 3
4 50 17 6
5 50 9 4
6 51 5 5
7 50 9 9
Mean ± SEM (p = 0.050) 50 ± 0.34 14.57 ± 4.24 8.00 ± 1.90
Type 1 diabetes
1 49 24 19
2 56 19 7
3 51 11 6
4 55 11 5
5 52 10 1
Mean ± SEM (p = 0.007) 53 ± 1.3 14.75 ± 2.72 7.87 ± 2.98
 Normal volunteers: euglycemia: mean glucose 99 mg/dl. Type 1 diabetes: euglycemia: mean glucose 98 mg/dl.
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hypoglycemia was 7.73% in normal volunteers and 9.43% in sub-
jects with diabetes. The 3-D plots showed clearly the demarcated
blind spot, conﬁrming subject ﬁxation. The 3-D response analysis
demonstrated some loss of central peak in all subjects during
hypoglycemia. The 3-D responses in a subject with diabetes and
in a subject without diabetes are shown (Fig. 1).
3.4. Contrast sensitivity
In subjects with and without diabetes, mean actual contrast
sensitivity decreased by 0.42 (p = 0.0004) and 0.36 (p < 0.001) from
euglycemia to hypoglycemia respectively. A temporary central sco-
toma was reported during hypoglycemia in 5/5 subjects with dia-
betes and 3/7 subjects without diabetes. Hypoglycemia resulted in
up to 6-fold decrease in contrast sensitivity.Fig. 1. 3-Dimensional response in: (A) subject with type 1 diabetes mellitus and (B)
normal volunteer. During hypoglycemia and euglycemia the blood glucose levels
were 50 mg/dl and 97 mg/dl respectively. The three dimensional response density
plots showed a signiﬁcant decrease in amplitude during hypoglycemia in the
subject with type 1 diabetes and in the normal volunteer. nV/deg2 = nanovolts per
degrees squared.4. Discussion
This pilot study is the ﬁrst to demonstrate signiﬁcant diminu-
tion of central retinal function in individuals with and without dia-
betes during acute hypoglycemia. Central retinal function
decreased consistently in all subjects with diabetes and this reduc-
tion was signiﬁcantly greater than the reduction observed in
peripheral retinal function. There were also signiﬁcant reductions
in contrast sensitivity during hypoglycemia.
Retinal elements responsible for vision are distributed in an
inhomogeneous fashion across the visual ﬁeld. The fovea has high-
est cone density; the central part of the fovea is rod free. The in-
creased concentration of cones in the central part of the retina is
responsible for the superior acuity, and is associated with high
metabolic demands. The foveal area is avascular. Delivery of met-
abolic substrates to this area is maintained through the extra-
retinal, choroidal circulation (Provis, 2001; Wybar, 1954). Glyco-
lytic and oxidative metabolism plays a major role in maintaining
retinal function (Winkler, 1981). It is possible that during hypogly-
cemia, the cells of central retina are not able to meet their meta-
bolic demands due to decreased supply of glucose as well as
decreased production of endogenous glucose by glycolytic
pathways.
There were two participants without diabetes in whom the de-
crease in the amplitude of the P1 wave from euglycemia to hypo-
glycemia was modest and of similar magnitude in both the central
and peripheral parts of the retina. In these subjects, the 3-D re-
sponse decreased in the central rings during hypoglycemia by only<1% and 8%. The reason for this is unclear. In contrast, in all ﬁve
participants with diabetes, there was greater change in central ver-
sus peripheral retinal function during hypoglycemia. None of the
participants had retinopathy. It is possible that individuals with
retinal disease have greater sensitivity to hypoglycemia. This is
an area for future study.
The acute adverse effects of low blood glucose levels on vision
in healthy individuals with type 1 diabetes have important short-
term safety implications (Cryer, 2008; McFarland, Halperin, & Ni-
ven, 1946; Perlmuter, Flanagan, Shah, & Singh, 2008). The glycemic
threshold for these visual effects is not known. It is important for
individuals with diabetes to recognize vision problems to avoid
impairment with driving and other activities. There may also be
long-term consequences of low glucose levels on vision. Sustained
hypoglycemia has been associated with loss of vision and retinal
degeneration in glucagon receptor knock out mice (Umino et al.,
2006). It is not known if individuals with diabetes who experience
frequent and prolonged hypoglycemia are at higher risk for visual
loss.
1626 M.I. Khan et al. / Vision Research 51 (2011) 1623–1626In summary, this pilot study demonstrates for the ﬁrst time,
that the central retina is more sensitive to the effects of hypoglyce-
mia than the peripheral retina, resulting in impaired central vision.
Possible long-term reduction in retinal function from chronic
hypoglycemia warrants further investigation.Acknowledgments
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